首页> 外文期刊>TMR Integrative Medicine >TCM aerosol inhalation treatment in acute exacerbations of chronic bronchitis: a meta-analysis
【24h】

TCM aerosol inhalation treatment in acute exacerbations of chronic bronchitis: a meta-analysis

机译:中药气雾剂吸入治疗慢性支气管炎急性加重的Meta分析

获取原文
           

摘要

Abstract Objectives: To determine whether traditional Chinese medicine (TCM) aerosol inhalation treatment is effective in the treatment of acute exacerbation of chronic bronchitis. Methods: Search double-blind randomised clinical trials (RCT) about the use of TCM aerosol inhalation in patient with acute exacerbation of chronic bronchitis via data base including Chinese biomedicine literature database, Wanfang Data, CNKI, Pubmed, EMBASE and Cochrane Library from the beginning to October 2016. Quality evaluation, data extraction and data analysis of these RCT was carried out with reference to the Cochrane systematic review. Results: 16 studies with 738 patients in TCM aerosol inhalation group and 675 in control group were included. The results of meta-analysis showed, (1) TCM aerosol inhalation group could improve the total cure rate. (2) TCM aerosol inhalation could increase the expression of IL-2 while decrease the expression of IL-8 and MDA in sputum and blood. (3) TCM aerosol inhalation could improve the symptoms of cough, cough with sputum, cough with dyspnea and lung wet rales. It also improve the symptoms of cough, expectorate and lung wet rales. (4) Shorten the time of cough and lung rale. (5) The adverse reactions were light only with 1 occurrence of nausea and vomiting. Conclusions: The use of TCM aerosol inhalation in the treatment of acute exacerbation of chronic bronchitis was effective. However, the inclusion researches quality were not very high, which only provided limited evidence for clinical application. Higher-quality randomized controlled trials were needed for further study.
机译:摘要目的:探讨中药气雾剂吸入治疗慢性支气管炎急性加重是否有效。方法:从一开始就通过包括中国生物医学文献数据库,万方数据,CNKI,Pubmed,EMBASE和Cochrane库在内的数据库搜索关于中药气雾剂吸入治疗慢性支气管炎急性加重患者的双盲随机临床试验(RCT)至2016年10月。参考Cochrane系统评价对这些RCT进行质量评估,数据提取和数据分析。结果:纳入16项研究,中药雾剂吸入组738例,对照组675例。荟萃分析结果表明:(1)中药雾化吸入组可提高总治愈率。 (2)中药气雾吸入可增加痰液和血液中IL-2的表达,同时降低IL-8和MDA的表达。 (3)吸入中药气雾剂可改善咳嗽,痰咳,呼吸困难咳嗽和肺湿罗音的症状。它还可以改善咳嗽,咳痰和肺湿罗音的症状。 (4)缩短咳嗽和肺部罗音的时间。 (5)不良反应较轻,仅出现恶心和呕吐1次。结论:中药气雾剂吸入治疗慢性支气管炎急性加重是有效的。但是,纳入研究的质量不是很高,仅为临床应用提供了有限的证据。需要更高质量的随机对照试验以进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号